Home › Funds › Patient Capital Management, LLC › CVS

Patient Capital Management, LLC position in CVS

CVS HEALTH CORP · Consumer Staples

Patient Capital Management, LLC reported holding 969,967 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$83.1M, representing 2.81% of its reported portfolio and ranking #20 among its reported holdings. Patient Capital Management, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)969.97K sh
Reported value held$83.12M
Portfolio Weight2.81%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Capital Management, LLC's CVS position evolved

Patient Capital Management, LLC first disclosed a stake in CVS in Q3 2023 at 605,120 shares (US$42.2M). The position peaked in Q2 2026 at 1,235,505 shares, worth US$127.8M. Across 13 filings, Patient Capital Management, LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 969,967 shares valued at US$83.1M — a reduction of -265,538 shares quarter over quarter.. Notable position changes include a 29% increase in Q2 2024 (shares rose 8% over the following quarter), a 69% increase in Q4 2024 (shares rose 53% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 605.12K $42.25M New
Q4 2023 600.98K $47.45M Reduce
Q1 2024 572.57K $45.67M Reduce
Q2 2024 739.71K $43.69M Add
Q3 2024 769.10K $48.36M Add
Q4 2024 1.30M $58.29M Add
Q1 2025 1.33M $89.81M Add
Q2 2025 1.24M $85.67M Reduce
Q3 2025 1.24M $93.48M Hold
Q4 2025 1.23M $97.73M Reduce
Q1 2026 1.36M $97.47M Add
Q2 2026 1.24M $127.81M Reduce
Q3 2026 969.97K $83.12M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 31 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has Patient Capital Management, LLC held CVS?

Patient Capital Management, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Patient Capital Management, LLC's current position in CVS?

As of Q3 2026, Patient Capital Management, LLC holds 969.97K shares of CVS (CVS HEALTH CORP), valued at $83.12M, representing 2.81% of its reported portfolio and ranking #20.

Has Patient Capital Management, LLC been buying or selling CVS?

In the latest 13F filing (Q3 2026), Patient Capital Management, LLC reduced its position in CVS. The position peaked in Q2 2026 at 1.24M shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.